# A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants

> **NCT06655194** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 38 (actual)

## Conditions studied

- Bioequivalence
- Healthy Volunteers
- Platelet Aggregation Inhibition

## Interventions

- **DRUG:** Acetylsalicylic Acid (Aspirin, BAYE004465, UI1610477)
- **DRUG:** Acetylsalicylic Acid (BAYE004465, UI1615160)

## Key facts

- **NCT ID:** NCT06655194
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-26
- **Primary completion:** 2025-04-06
- **Final completion:** 2025-04-06
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2025-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06655194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06655194, "A Study to Learn if There is a Difference in the Blood Levels of Acetylsalicylic Acid When Taken as Different Chewable Tablets on an Empty Stomach by Healthy Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06655194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*